How did the 22% YoY revenue growth in Q3 2025 impact GAAP operating income margin?

DexCom, Inc. (DXCM) reported a notable improvement in its GAAP operating income margin in Q3 2025, even with strong year-over-year revenue growth. The 22% year-over-year revenue increase to $1.209 billion in Q3 2025, up from $994.2 million in Q3 2024, coincided with a substantial expansion of the company's GAAP operating profitability.1

Key figures for Q3 2025 highlight this impact:

• Revenue: $1.209 billion, representing a 22% increase from Q3 2024.1
• GAAP Operating Income: $242.5 million.1
• GAAP Operating Income Margin: 20.1% of revenue.1

Comparing this to Q3 2024, where GAAP operating income was $152.0 million on revenues of $994.2 million, the operating income margin was approximately 15.3%. This indicates that the GAAP operating income margin increased by 480 basis points (4.8%) year-over-year, reaching 20.1% in Q3 2025.1 This significant expansion suggests that DexCom was able to grow its revenue while simultaneously improving its operational efficiency and leverage, leading to a higher proportion of each revenue dollar translating into operating profit.